Olaplex Holdings, INC 8-K filings

Olaplex Holdings, Inc. has been acquired by Henkel US Operations Corporation, with shares delisted from Nasdaq and reporting obligations suspended.

Olaplex Holdings, Inc. has reached a preliminary settlement in its stockholder derivative litigation, agreeing to implement corporate governance reforms.

Olaplex Holdings, Inc. announced first quarter 2026 financial results, showing a 2.5% increase in net sales to $99.4 million, alongside a net loss of $5.3 million, as the company navigates its pending acquisition by Henkel.

Olaplex Holdings, Inc. has entered into a definitive agreement to be acquired by Henkel US Operations Corporation for $2.06 per share in cash, valuing the company at approximately $1.4 billion.

Olaplex Holdings, Inc. announced fourth quarter sales growth of 4.3% but reported increased net losses for both the quarter and fiscal year 2025, alongside a cautious 2026 outlook.

Olaplex Holdings, Inc. reported a 3.8% decrease in net sales to $114.6 million and a 24.8% drop in net income for Q3 2025, while reaffirming its full-year guidance.

Olaplex Holdings, Inc. announced its first acquisition in over a decade, purchasing Boston-based biotech company Purvala Bioscience for $10.5 million to drive future product innovation.

Olaplex Holdings, Inc. announced a net loss of $7.7 million for the second quarter of 2025, despite a 2.3% increase in net sales to $106.3 million.

Olaplex Holdings, Inc. has appointed Jerome Griffith, a seasoned executive with extensive experience in the retail and consumer goods industries, as a Class I director to its Board of Directors.

Olaplex Holdings, Inc. held its 2025 Annual Meeting of Stockholders, confirming the election of three Class I directors, the advisory approval of executive compensation, and the ratification of Deloitte & Touche LLP as its independent auditor.

Olaplex Holdings, Inc. announced its first quarter 2025 financial results, showing a slight decrease in net sales but progress in its transformation strategy.

Stephen J. Bacica resigned as Chief Accounting Officer of Olaplex Holdings, Inc., effective April 24, 2025, and Kenneth F. Egan was reappointed as Interim Chief Accounting Officer, effective April 28, 2025.

Olaplex Holdings, Inc. announces the appointment of Pamela Edwards as a Class II director and Stephen J. Bacica as Chief Accounting Officer, effective March 19, 2025.

Olaplex Holdings, Inc. announced its financial results for Q4 and fiscal year 2024, with Q4 results exceeding expectations despite overall sales decreases for the year.

Olaplex Holdings, Inc. reports the resignation of Janet Gurwitch from the Board of Directors and the appointment of Christine Dagousset to the Audit Committee, both effective December 2, 2024.

Olaplex announced a decrease in net sales and net income for the third quarter of 2024, and revised its full-year guidance downward due to international business realignment and slower-than-expected demand.

Olaplex Holdings, Inc. reports the resignation of its Senior Vice President of Accounting, Kristi Belhumeur, effective October 11, 2024.

Olaplex Holdings has appointed Catherine Dunleavy as Chief Operating Officer and Chief Financial Officer, effective immediately, finalizing a previously announced leadership transition.

Olaplex's second quarter results showed a slight decrease in net sales but the company reaffirmed its full-year 2024 guidance.

Olaplex Holdings, Inc. has announced the appointment of Catherine Dunleavy as its new Chief Operating Officer and Chief Financial Officer, effective August 13, 2024.

Olaplex Holdings, Inc. has amended its Restated Certificate of Incorporation to limit officer liability and clarify corporate opportunity provisions, following shareholder approval at the 2024 Annual Meeting.

Olaplex Holdings, Inc. has appointed Paul Kosturos as interim Chief Financial Officer, effective May 6, 2024, following the resignation of Eric Tiziani.

Olaplex's first quarter 2024 results show a 13.1% decrease in net sales compared to the same period last year, though the company maintains its full-year guidance.

Olaplex announced the resignation of its CFO, Eric Tiziani, effective May 3, 2024, and the appointment of Paul Kosturos as interim CFO, while also reaffirming its Q1 2024 net sales guidance.

Olaplex's Q4 2023 results showed a 14.5% decrease in net sales, while full-year 2023 net sales declined by 34.9%, with the company providing 2024 guidance indicating a potential stabilization.